| abstract |
Antibodies that selectively bind glycosylated PD-1 relative to non-glycosylated PD-1 are provided. In some aspects, PD-1 polypeptides comprising glycosylated amino acid positions are also provided. Methods of making and using such antibodies and polypeptides (eg, for the treatment of cancer) are also provided. |